Auto-anticorps et pathologies hépatiques

Abuaf, 1992, Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis, Hepatology, 16, 892, 10.1002/hep.1840160407 Aguilera, 2001, Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation, Clin. Exp. Immunol., 126, 535, 10.1046/j.1365-2249.2001.01682.x Alvarez, 1999, International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis, J. Hepatol., 31, 929, 10.1016/S0168-8278(99)80297-9 Andries, 2001, Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine, Transplantation, 72, 262, 10.1097/00007890-200107270-00018 Baeres, 2002, Establisment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics, Gut, 51, 259, 10.1136/gut.51.2.259 Ballot, 2004, Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases, J. Autoimmun., 22, 153, 10.1016/j.jaut.2003.11.002 Ballot, 2003, Identification of rats targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis, Clin. Chem., 49, 634, 10.1373/49.4.634 Ballot, 2000, Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis, J. Hepatol., 33, 208, 10.1016/S0168-8278(00)80361-X Bandin, 1996, Specificity and sensitivity of gp210 autoantibodies detected using an enzymelinked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis, Hepatology, 23, 1020, 10.1002/hep.510230512 Bayraktar, 1997, A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases, Hepato-gastroenterology, 44, 417 Bellary, 1996, Autoimmune hepatitis and/or hepatitis C: how to decide?, Hepatology, 23, 647, 10.1002/hep.510230334 Ben-Ari, 2001, Autoimmune hepatitis and its variant syndromes, Gut, 49, 589, 10.1136/gut.49.4.589 Bianchi, 1993, Autoimmune hepatitis: the lesson of discovery of hepatitis C virus, J. Hepatol., 18, 273, 10.1016/S0168-8278(05)80268-5 Billing, 1995, Nuclear localization of the ulcerative colitis specific perinuclear antineutrophil cytoplasmic antibody (pANCA) reactive antigen, Am. J. Pathol., 147, 979 Bogdanos, 2003, Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection, Dig. Liver. Dis., 35, 801, 10.1016/S1590-8658(03)00466-3 Bridoux-Henno, 2004, Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody, Clin. Gastroenterol. Hepatol., 2, 825, 10.1016/S1542-3565(04)00354-4 Cacoub, 1994, Mixed cryoglobulinemia and hepatitis C virus, Am. J. Med., 96, 124, 10.1016/0002-9343(94)90132-5 Chen, 1998, Caracterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis, J. Gastroenterol. Hepatol., 13, 483, 10.1111/j.1440-1746.1998.tb00673.x Chretien-Leprince, 2005, Diagnostic value of anti-F-actin antibodies in a french multicenter study, Ann. N. Y. Acad. Sci., 1050, 266, 10.1196/annals.1313.028 Claise, 1996, Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases, Liver, 16, 28, 10.1111/j.1600-0676.1996.tb00700.x Coppel, 1988, Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase, 85, 7317 Corpechot, 2005, Les anticorps anti-nucléaires ont-ils une valeur pronostique au cours de la cirrhose biliaire primitive?, Gastroenterol. Clin. Biol., 29, 888, 10.1016/S0399-8320(05)86374-2 Courvalin, 1990, The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore, J. Clin. Invest., 86, 279, 10.1172/JCI114696 Courvalin, 1990, Identification and characterization of autoantibodies against the nuclear envelope lamin B. receptor from patients with primary biliary cirrhosis, J. Exp. Med., 172, 961, 10.1084/jem.172.3.961 Czaja, 1997, Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis, Dig. Dis. Sci., 42, 1688, 10.1023/A:1018809431189 Czaja, 1997, Antibodies to single stranded and double stranded DNA in antinuclear antibody-positive type 1 autoimmune hepatitis, Hepatology, 26, 567, 10.1002/hep.510260306 Czaja, 2002, Antibodies to soluble liver antigen/liver pancreas and H LA risk factors for type 1 autoimmune hepatitis, Am. J. Gastroenterol., 97, 413, 10.1111/j.1572-0241.2002.05479.x Czaja, 2003, Autoantibodies in the diagnosis and management of liver disease, J. Clin. Gastroenterol., 37, 315, 10.1097/00004836-200310000-00011 Czaja, 2003, Frequency and significance of antibodies to chromatin in autoimmune hepatitis, Dig. Dis. Sci., 48, 1658, 10.1023/A:1024748714580 Czaja, 2002, Frequency and significance of antibodies to soluble liver antigen/ liver pancreas in variant autoimmune hepatitis, Autoimmunity, 35, 475, 10.1080/0891693021000054101 Czaja, 2004, Nonstandard antibodies as pronostic markers in autoimmune hepatitis, Autoimmunity, 37, 195, 10.1080/08916930410001702469 Dubel, 1995, Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis, J. Hepatol., 23, 674, 10.1016/0168-8278(95)80033-6 Dubel, 1998, Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation, J. Hepatol., 28, 169, 10.1016/S0168-8278(98)80220-1 Dubel, 1998, High incidence of anti-tissue antibodies in patients experiencing chronic liver allograft rejection, Transplantation, 65, 1072, 10.1097/00007890-199804270-00011 Duclos-Vallee, 2005, Hépatites autoimmunes, Gastroenterol. Clin. Biol., 29, 1236, 10.1016/S0399-8320(05)82207-9 Duclos-Vallee, 2000, Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis, J. Hepatol., 33, 163, 10.1016/S0168-8278(00)80175-0 Duclos-Vallée, 1994, High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis, Br. Med. J., 309, 846, 10.1136/bmj.309.6958.846 Duclos-Vallée, 2003, A 10 years follow up study of patients transplanted for autoimmune hepatitis : histological recurrence precedes clinical and biochemical recurrence, Gut, 52, 893, 10.1136/gut.52.6.893 Gregorio, 1997, A 12 year-old girl with antimitochondrial antibody-positive autoimmune hepatitis, J. Hepatol, 27, 751, 10.1016/S0168-8278(97)80093-1 Grimbert, 1996, Antimitochondrial antibodies in patients with chronic hepatitis C, Liver., 16, 161, 10.1111/j.1600-0676.1996.tb00722.x Grotzinger, 1996, A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots, Mol. Cell. Biol., 16, 1150, 10.1128/MCB.16.3.1150 Haddad, 1992, Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease, Lancet, 339, 321, 10.1016/0140-6736(92)91645-O Heneghan, 2001, Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults, Hepatology, 34, 270, 10.1053/jhep.2001.26756 Homberg, 1987, Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of ≪ autoimmune ≫ hepatitis, Hepatology, 7, 1333, 10.1002/hep.1840070626 Huguet, 2004, Heterogeneous nuclear ribonucleoprotein A2/B1 identified as an autoantigen in autoimmune hepatitis by proteome analysis, Proteomics, 4, 1341, 10.1002/pmic.200300757 Huguet, 2004, Analytic study of dot blotting for the detection of antiJo-1, anti-M2, anti-ribosomes and anti-LKM, Ann. Biol. Clin., 62, 423 Inui, 2005, Antibodies against cytokeratin 8/18 in patient with de novo autoimmune hepatitis after livingdonor liver transplantation, Liver Transpl., 44, 504, 10.1002/lt.20404 Itoh, 1998, Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis, J. Gastroenterol. Hepatol., 13, 257, 10.1111/j.1440-1746.1998.01553.x Johanet, 2006, Autoanticorps et hépatites virales, Rev. Fr. Lab., 384, 20 Johanet, 2005, Hépatites auto-immunes: pertinence des anticorps anti-SLA et des anticorps anti-LC1, Spectra Biol., 145, 30 Johanet, 1999, Auto-anticorps en hépatologie, Pathol. Biol., 47, 997 Johson, 1993, Meeting report: international autoimmune hepatitis group, Hepatology, 18, 998, 10.1002/hep.1840180435 Kerkar, 1998, De-novo autoimmune hepatitis after liver transplantation, Lancet, 351, 409, 10.1016/S0140-6736(97)06478-7 Konstantinov, 1995, Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope, Clin. Immunol. Immunopathol., 74, 89, 10.1006/clin.1995.1013 Lapierre, 1999, Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis, Gastroenterology, 116, 643, 10.1016/S0016-5085(99)70186-1 Lassoued, 1988, Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis, Clin. Exp. Immunol., 174, 283 Lenzi, 1995, Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection, Gut, 36, 749, 10.1136/gut.36.5.749 Li, 2000, Frequency and significance of antibodies to chromatin in type 1 autoimmune hepatitis, J. Gastroenterol. Hepatol., 15, 1176, 10.1046/j.1440-1746.2000.02325.x Lin, 1996, Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR, Hepatology, 23, 57, 10.1002/hep.510230109 Ma, 2002, Antibodies to conformationnal epitopes of soluble liver antigen define a severe form of autoimmune liver disease, Hepatology, 35, 658, 10.1053/jhep.2002.32092 Manns, 1987, Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen, Lancet, 1, 292, 10.1016/S0140-6736(87)92024-1 Marcellin, 1995, Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction, J. Hepatol., 22, 364, 10.1016/0168-8278(95)80291-6 Martini, 1988, Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2, Hepatology, 8, 1662, 10.1002/hep.1840080632 Mieli-Vergani, 2004, De novo autoimmune hepatitis after liver transplantation, J. Hepatol., 40, 3, 10.1016/j.jhep.2003.10.022 Miyachi, 2003, Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study, J. Autoimmun., 20, 247, 10.1016/S0896-8411(03)00033-7 Miyagawa-Hayashino, 2004, Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation, Transplantation, 78, 128, 10.1097/01.TP.0000132328.33460.43 Moteki, 1996, Epitope mapping and reactivity of autoantibodies to the E2 component of 2oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex, Hepatology, 23, 436, 10.1002/hep.510230307 Muratori, 1998, Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis, Gut, 42, 721, 10.1136/gut.42.5.721 Muratori, 2003, Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis, Am. J. Gastroenterol., 98, 431, 10.1111/j.1572-0241.2003.07257.x Nakamura, 2005, Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis, J. Hepatol., 42, 386, 10.1016/j.jhep.2004.11.016 Nickowitz, 1993, Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210, J. Exp. Med., 178, 2237, 10.1084/jem.178.6.2237 Nickowitz, 1994, Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis, Gastroenterology, 106, 193, 10.1016/S0016-5085(94)95333-3 Obermayer-Straub, 2000, Autoimmune hepatitis, J. Hepatol., 32, 181, 10.1016/S0168-8278(00)80425-0 Pawlotsky, 1992, Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis, Hepatology, 16, 127, 10.1002/hep.1840160121 Peoc'h, 2001, Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virusrelated infection, Am. J. Gastroenterol., 96, 2978 Petz, 2002, A cause of late dysfunction after pediatric liver transplantation : de novo autoimmune hepatitis, 34, 1958 Reynes, 1998, Récidive des cirrhoses biliaires primitives et des hépatites auto-immunes : arguments histopathologiques et immunologiques, 107 Romero-Gomez, 2004, Serum immunological profile in patients with chronic autoimmune cholestasis, Am. J. Gastroenterol., 99, 2150, 10.1111/j.1572-0241.2004.40416.x Salcedo, 2002, Reponse to steroids in de novo autoimmune hepatitis after liver transplantation, Hepatology, 35, 349, 10.1053/jhep.2002.31167 Sanonno, 1995, Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia, Hepatology, 21, 305 Soulie, 1993, Characterization of anti-mitochondrial antibodies type 2 (anti-M2): comparison of two techniques, western blotting and indirect immunofluorescence, Ann. Clin. Biol., 51, 707 Tartakovsky, 1995, Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope, Hepatology, 21, 495 Terjung, 2000, Atypical p-ANCA in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines, Gastroenterology, 119, 0, 10.1053/gast.2000.9366 Torres Collado, 2005, Anti t-RNP/SLA/LP autoantibodies, Comparative sudy using in house ELISA with a recombinant 48,8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs, Liver Int., 25, 410, 10.1111/j.1478-3231.2005.01079.x Treichel, 1993, Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virusinduced chronic active hepatitis, J. Hepatol., 19, 55, 10.1016/S0168-8278(05)80176-X Treichel, 1994, Demographics of antiasialoglycoprotein receptor autoantibodies in autoimmune hepatitis, Gastroenterology, 107, 799, 10.1016/0016-5085(94)90129-5 Vergani, 2004, Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group, J. Hepatol., 41, 677, 10.1016/j.jhep.2004.08.002 Vitozzi, 2002, Anti-soluble liver antigen/liver pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis, Autoimmunity, 35, 485, 10.1080/0891693021000056712 Vitozzi, 2002, Auto-antibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein, J. Immunol. Methods, 262, 103, 10.1016/S0022-1759(02)00016-9 Vitozzi, 2004, Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection, Autoimmunity, 37, 217, 10.1080/08916930410001686260 Wasmuth, 2004, The presence of nonorgan-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C, BMC Infect. Dis., 4, 4, 10.1186/1471-2334-4-4 Wesierka-Gadek, 1996, Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis, Gastroenterology, 110, 840, 10.1053/gast.1996.v110.pm8608894 Wies, 2000, Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis, Lancet, 335, 1510, 10.1016/S0140-6736(00)02166-8 Worman, 1988, A lamin B receptor in the nuclear envelope, 85, 8531 Wu, 2002, Proteinase 3 and dihydrolipoamide dehydrogenase (E3) are major autoantigens in hepatitis C virus (HCV) infection, Clin. Exp. Immunol., 128, 347, 10.1046/j.1365-2249.2002.01827.x Yamamoto, 1993, Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C viruspositive and -negative sera, Gastroenterology, 104, 1762, 10.1016/0016-5085(93)90657-X Yamamoto, 1997, A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type 2 (AIH2) and chronic hepatitis C virus (HCV) infection : a sensitive and quantitative radioligand assay, Clin. Exp. Immunol., 108, 396, 10.1046/j.1365-2249.1997.4071302.x Yee, 2004, Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance, J. Viral. Hepat., 11, 459, 10.1111/j.1365-2893.2004.00530.x Zachou, 2004, Autoantibodies and autoantigens in autoimmune hepatitis : important tools in clinical practice and to study pathogenesis of the disease, J. Autoimmune Dis., 1, 2, 10.1186/1740-2557-1-2